| | Merck's first-quarter profit beats on Keytruda boost | | Merck & Co Inc reported a higher-than-expected first-quarter profit on Tuesday and raised its earnings and sales forecasts for the year, thanks to surging sales of its blockbuster cancer immunotherapy Keytruda. | | | | | Pfizer posts earnings beat, raises 2019 profit forecast | | Pfizer Inc beat Wall Street estimates for quarterly profit and tweaked its earnings forecast for the year on Tuesday, as it reported rising sales of cancer drug Ibrance and pneumonia vaccine Prevnar, pushing shares in the drugmaker higher. | | | | | | | | Related Video | | | | | | | | | | | Make sense of the market with highlights of valuable financial information and reports along with compelling investment insights. Register Today | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | » » MORE NEWSLETTERS | | |